| scholarly article | Q13442814 |
| P2093 | author name string | Compston DA | |
| Miller DH | |||
| Milligan NM | |||
| P2860 | cites work | Ability of isoprinosine to restore interleukin-2 production and T cell proliferation in autoimmune mice | Q68942593 |
| [Clinical and immunological improvement of remittent multiple sclerosis by isoprinosine. Randomized pilot study] | Q68964394 | ||
| Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS | Q69351477 | ||
| Moderate efficacy of isoprinosine as a therapy for rheumatoid arthritis | Q72383099 | ||
| Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients | Q72665999 | ||
| Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex | Q72672514 | ||
| Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases | Q72700913 | ||
| Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) | Q22241644 | ||
| Randomised double blind controlled trial of cyclosporin in multiple sclerosis | Q30495856 | ||
| Immunosuppressive effects of isoprinosine in man: a comparison to chlorambucil effects in multiple sclerosis | Q33412934 | ||
| Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis | Q33562594 | ||
| A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects | Q33628316 | ||
| Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. | Q34253953 | ||
| New diagnostic criteria for multiple sclerosis: guidelines for research protocols | Q34271601 | ||
| Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro | Q34627351 | ||
| Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group | Q34730962 | ||
| Subacute sclerosing panencephalitis in black children--a review of 18 cases | Q37969258 | ||
| Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy | Q38169588 | ||
| Inosiplex in the Treatment of Subacute Sclerosing Panencephalitis | Q39552955 | ||
| Progressive rubella panencephalitis: immunovirological studies and results of isoprinosine therapy | Q39553444 | ||
| Exacerbations of multiple sclerosis in patients treated with gamma interferon | Q40797798 | ||
| Limiting and repairing the damage in multiple sclerosis | Q41602445 | ||
| Overview of azathioprine treatment in multiple sclerosis | Q42033600 | ||
| Methisoprinol in the treatment of multiple sclerosis. A pilot study | Q43517712 | ||
| Changes in visual evoked potentials in patients with multiple sclerosis treated with isoprinosine and amantadine | Q43531006 | ||
| A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis | Q43651803 | ||
| The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group | Q45860274 | ||
| Inosiplex and amyotrophic lateral sclerosis. Therapeutic trial in patients on Guam. | Q54097797 | ||
| Isoprinosine in treatment of acute viral encephalitis | Q66703516 | ||
| Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study | Q68127972 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | placebo | Q269829 |
| placebo-controlled trial | Q108853737 | ||
| P304 | page(s) | 164-168 | |
| P577 | publication date | 1994-02-01 | |
| P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
| P1476 | title | A placebo-controlled trial of isoprinosine in patients with multiple sclerosis | |
| P478 | volume | 57 |
| Q39113644 | Associated Inosine to interferon: results of a clinical trial in multiple sclerosis. |
| Q35182733 | Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives |
| Q41745131 | Current immunotherapy in multiple sclerosis |
| Q26782408 | Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review |
| Q92553174 | Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases |
| Q33770448 | Magnetic resonance (MR) imaging as a marker for multiple sclerosis |
| Q72176233 | Neurology |
| Q36815380 | Novel oral agents for multiple sclerosis |
| Q33571873 | Outcomes assessment of drug treatment in multiple sclerosis clinical trials |
| Q29030703 | Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives |
Search more.